verse nitrate tolerance have mainly focused on the administration of thiol compounds9-12 since experimental studies have suggested that depletion of intracellular sulfhydryl pools might be responsible for the induction of nitrate tolerance. 13 However, in vitro and in vivo data on sulfhydryl groups and GTN interactions are becoming increasingly contradictory.14-17 In a recent study,18 we found a tolerance-independent potentiation of effects of GTN by the sulfhydryl donor N-acetylcysteine (NAC) on canine epicardial arteries and peripheral resistance vessels. No reversal of a GTN-specific tolerance by NAC in large epicardial arteries and the venous capacitance system of the dog was observed; however, the augmentation of GTN effects in the tolerant and nontolerant states by NAC was attributed to the existence of an extracellular pathway since the stimulatory effect of GTN on the target enzyme guanylyl cyclase was potentiated in the presence of canine plasma.18 Furthermore, Fung et al19 demonstrated that tolerance in GTN, glyceryl trinitrate; AB, autonomic blockade (10 mg/kg+10 mg/kg/hr hexamethonium, 0.5 mg/kg methylatropine, 2 mg/kg nadolol), NE, norepinephrine (i.v. infusion 0.15 j.g/kg/min); Meth, 100 mg/kg L-methionine.
*GTN dosages were given in ,tg/kg/min. vascular strips was partially reversed in the presence of human plasma, indicating an extracellular interaction. Thus, clinical and experimental observations of NAC effects on GTN actions cannot be used to evaluate the significance of a potential intracellular sulfhydryl depletion and its replenishment for GTN tolerance in vivo.
In contrast to NAC, L-methionine does not contain a free sulfhydryl group. If methionine is to act as a sulfhydryl donor, intracellular conversion of methionine to cysteine via the transsulfuration pathway is necessary. 20 Thus, methionine-induced potentiation of GTN action would point more specifically to an intracellular interaction between the sulfhydryl donor and the organic nitrate.
The aim of the present study was, therefore, to analyze directly in vivo the effectiveness of sulfhydryl group supplementation by L-methionine on tolerant large coronary arteries and veins of the dog. Purified guanylyl cyclase and cultured vascular smooth muscle cells of rat aorta were used to study potential intracellular or extracellular mechanisms responsible for this interaction.
Methods

Animals and Experimental Preparation
Seventeen dogs weighing [23] [24] [25] [26] [27] [28] [29] [30] [31] kg were used in different experimental protocols (Table 1) . In all dogs (groups A-C) a common carotid artery was translocated into a cutaneous loop at the ventral surface of the neck. For chronic instrumentation (group C), the dogs were thoracotomized while under pentobarbital anesthesia with sterile conditions. The dogs were equipped for continuous measurement of coronary artery flow and external epicardial artery diameter of the circumflex branch of the left coronary artery diameter, as described previously.'8'22 Dogs with <100-,um epicardial artery dilation in response to a GTN test injection were excluded. Coronary flow was measured with a Gould SP 2202 flowmeter, coronary artery external diameter was measured with ultrasonic time crystals, and arterial pressure was measured with a Statham P-23 pressure transducer connected to the carotid artery cannula; heart rate was derived from an arterial pressure signal.
Anesthetized (27 mg/kg plus 0.5 mg/kg/min pentobarbital), areflexic dogs without GTN pretreatment (group B, n=5) were used to test the effect of GTN on mean arterial and central venous pressures before and after methionine administration. At the end of the experimental protocol, a polyethylene catheter was inserted into the external jugular vein transcutaneously for longterm GTN infusion (5 days) via a small mobile precision infusion pump (model AS30C, Baxter, Travenol). Intervals of at least 2 weeks were allowed before starting long-term GTN infusions and the subsequent assessment of venous tone in the tolerant state (group B, n=4: GTN-pretreated dogs). Venous tone was assessed using a modification of the technique suggested by Gauer's group (Echt et al) . 23 In anesthetized dogs (27 mg/kg plus 0.05 mg/kg/min pentobarbital i.v.) with autonomic blockade (10 mg/kg plus 10 mg/kg/hr hexamethonium, 0.5 mglkg methylatropine, and 2 mg/kg nadolol) and vascular preconstriction with norepinephrine (0.15 ,ug/kg/min), mean and phasic central venous and arterial pressures were recorded continuously, and the effective vascular compliance of the total vascular system was obtained by relating changes in central venous pressure to the simultaneous changes in blood volume during a cycle of blood infusion, withdrawal, and reinfusion for 11 minutes, as described in detail previously.24 At the end of the experiments, the dogs were killed with an overdose of pentobarbital.
Experimental Protocols
Systemic hemodynamic measurements were performed in nontolerant dogs of group A (n=4) in response to three high-dose GTN test infusions (1.5, 5.0, and 15.0 ,g/kg/min) before and after L-methionine (30, 100, and 300 mg/kg). L-Methionine was infused over 10 minutes at a rate of 10 ml/min starting 20 minutes after the last GTN test infusion. Five minutes later, the three short-term GTN challenges were applied again with the same sequence, duration, and intervals.
In the dogs of group B (n=5, protocol 1, blockade before and after L-methionine (group B, GTN-pretreated dogs, n=4). For the assessment of large coronary artery diameter and hemodynamic effects before and after L-methionine in the nontolerant chronically instrumented dog (group C, n=8), two small doses of GTN (0.15 and 0.5 ,ug/kg/ min) were infused intravenously for 5 minutes each until steady-state conditions were reached. When coronary artery diameter returned to baseline, an L-methionine infusion (100 mg/kg i.v.) was started and continued for 10 minutes. Then, the dogs were challenged again with the same GTN concentrations (Figure 2) . Thereafter, tolerance was induced by infusing 1.5 ,ug/kg/min GTIN for 5 days (group C, GTN-pretreated dogs, n=5). Four days after starting the long-term GTN infusion, coronary artery diameter did not differ significantly from pretreatment diameters, indicating a nearcomplete loss of its initial vasodilator potency. The effects of methionine on nitrate-tolerant epicardial arteries were assessed on day 5. During the entire protocol (group C, tolerant dogs), the dogs received a continuous infusion of GTN (1.5 ,ug/kg/min). Additional GTN infusions were administered for 5 minutes each, yielding final concentrations of 3.0, 6.5, and 16.5 ,ug/kg/ min. After a 15-minute pause, L-methionine (100 mg/ kg) was infused for 10 minutes before rechallenging the dog with the same high GTN concentrations. During the protocols, changes in heart rate, mean arterial pressure, coronary flow, and coronary diameter were continuously recorded with a Watanabe linear recorder. Determination of Plasma Methionine, Cystine, and Homocystine Levels
The amino acid analysis was performed with an amino acid analyzer (LKB-Amino Acid Analysis System, Pharmacia, Freiburg, Germany) using a modification of the method originally described by Spackman et al. 25 With this technique, separation and quantitative determination of amino acids are performed after reaction with ninhydrin, yielding a purple substance absorbing maximally at 570 nm. This absorbance is a linear function of the amount of a-amino groups present, and the reaction provides a quantitative colorimetric assay for all organic compounds with a-amino groups. The reaction product with amino acids is monitored at 440 nm. The color recoveries for individual amino acids differ slightly. The coefficient of variation (CV) for standard mixtures is 1.5% at a loading of 10 nmol of amino acid (n =10 Blood pressure and heart rate in response to 1.5, 5.0, and 15.0 ,ug/kg/min were determined before and after the infusion of L-methionine at 30, 100, and 300 mg/kg in four dogs. All dogs tolerated L-methionine with respect to the two lower methionine concentrations, but three of four dogs became restless and vomited during infusion of methionine at the high concentration (300 mg/kg). The tachycardic response to GTN (5.0 and 15.0 gg/kg/min) was significantly enhanced after 100 mg/kg L-methionine but not after 30 mg/kg (Figure 1 ). L-Methionine and Nitrate Responsiveness in the Anesthetized, Areflexic, Nontolerant Dogs (Group B) Figure 2 shows the effects of L-methionine on the GTN dose-response curves in dogs under anesthesia and autonomic blockade. Autonomic blockade was used to minimize neurogenic counterregulation during adMethionie. 10 O MAP 100
z4.
- Effects of L-Methionine on GTN-Induced Coronary Vasodilation in Awake, Nontolerant, and Tolerant Dogs (Group C) Figure 3 shows the dose-dependent epicardial artery dilation to 0.15 and 0.5 ,ug/kg/min GTN before and after L-methionine administration, respectively. Increasing GTN concentrations caused a dose-dependent epicardial artery dilation that was not modified after infusion of L-methionine (100 mg/kg). There also was no enhancement of the GTN effects on mean arterial pressure, heart rate, and coronary flow. This figure also illustrates that L-methionine infusion per se had no effect on systemic and coronary hemodynamics since coronary artery diameter and all hemodynamic variables did not change significantly during methionine infusion. Under continuous exposure to GTN (1.5 ,g/ kg/min for 5 days), the coronary artery diameter returned to control levels, indicating a complete development of tolerance in large epicardial arteries in agreement with previous observations.21 The GTN concentration for half-maximal dilation was shifted to 16-fold higher dosages. In the tolerant state (Figure 4) Effects of L-Methionine Infusion (100 mg/kg) on Plasma Methionine, Cystine, and Homocystine Levels Table 3 summarizes the effects of L-methionine infusion in a concentration of 100 mg/kg on plasma methionine, cystine, and homocystine levels. L-Methionine caused a significant increase in plasma methionine levels (from 52±12 to 1,141±239 ,uM) and plasma cystine levels (from 12±4 to 26±7 ,uM) but not in homocystine concentrations.
Extracellular Enhancement of Nitrate-Induced Guanylyl Cyclase by L-Cysteine
In a cell-free in vitro system, the activity of purified soluble guanylate cyclase was significantly enhanced above basal values by GTN in a concentration of 100 ,uM ( Figure 5 ). The GTN-induced stimulation of guanylyl cyclase activity was significantly enhanced by L-Cysteine (0.1+ 1 mM) but not by homocysteine. Compared with plasma cystine levels achieved with L-methionine infusion (20-30 ,uM; see Table 3 ), higher L-cysteine concentrations are required in this guanylyl cyclase assay. This may be due to suboptimal conditions for enzyme activation in this assay and therefore does not establish a small potentiation by L-methionine of GTNinduced changes in systemic hemodynamics in nontolerant dogs, this potentiation did not include a modification of the GTN-induced large epicardial arterial and venous dilation in tolerant and nontolerant dogs. The significant increase in plasma cystine levels in response to L-methionine infusion, together with the observed enhancement of GTN biotransformation in the guanylyl cyclase assay by L-cysteine, indicates that at least part of the L-methionine-induced potentiation of GTN action may be due to an interaction between the L-methionine conversion product L-cysteine and the organic nitrate. The inability of L-methionine to reverse nitrate tolerance in large epicardial arteries and veins in vivo, however, strongly argues against sulfhydryl group depletion as the predominant tolerance mechanism in these vessels.
Nitrate Tolerance and the Sulfhydryl Concept
The sulfhydryl group concept of nitrate tolerance is based on in vitro findings that chronic administration of organic nitrates leads to tolerance and is accompanied by intracellular sulfhydryl group depletion.'4 Ignarro and coworkers28 demonstrated that in a cell-free system, activation of partially purified guanylyl cylase requires the presence of sulfhydryl groups. Furthermore, they observed that S-nitroso-cysteine caused a guanylyl cyclase activation that resembled that induced by nitric oxide. Based on these observations, they hypothesized that S-nitrosothiols may be reactive intermediates required for vascular smooth muscle relaxation by organic nitrates.
More recently, however, Grutter and Lemke'5 demonstrated that intracellular sulfhydryl group replenishment with cysteine (10-fold increase in sulfhydryl group content) had no influence on degree of tolerance of isolated bovine coronary arteries or on GTN-induced cyclic GMP accumulation. Subsequent studies in nontolerant and tolerant humans reported a potentiation of GTN effects by sulfhydryl donor NAC and sulfhydryl precursor L-methionine.9-12,28-30 However, the exact mechanism responsible for this potentiation14-19 remains controversial. Using chronically instrumented dogs as an in vivo model for nitrate tolerance, we found that the potentiation of GTN action by NAC was restricted to the nontolerant state, predominantly involved potentiation of GTN effects on resistance vessels, and did not include reversal of a high degree tolerance (shift to 17-fold higher dosages) in epicardial arteries and the venous capacitance system. 18 The demonstration of an additional extracellular pathway for the interaction between NAC and GTN led us to propose a modified sulfhydryl concept. We and others suggested that exogenously administered sulfhydryl groups augment GTN action mainly by intravascular (extracellular) formation of either nitric oxide or nitrosothiol compounds'8"19 at the resistance vessel level. This mechanism appears to be responsible for the potentiation of GTN action in nontolerant patients29'30 and for the partial reversal of a low-grade tolerance in humans.9 '10 Recent experimental data appear to support our hypothesis. Sellke and coworkers3' demonstrated that vessel size has great impact on the sensitivity to nitroglycerin. Biotransformation of GTN (i.e., the release of nitric oxide) in microvessels (diameter, <100 ,uM) was The present experiments provide four important results that may help to clarify possible mechanisms of interaction between L-methionine; its conversion product, L-Cysteine; and the organic nitrate. First, infusion of L-methionine in a concentration of 100 mg/kg causes a significant increase in plasma cystine concentrations (Table 3) , which indicates that this concentration of methionine is sufficient to increase intracellular sulfhydryl group content.
Second, we observed no change in intracellular sulfhydryl group content of rat aortic vascular smooth muscle cells after incubation with 1 mM L-methionine, a concentration comparable to plasma concentrations achieved with L-methionine infusions (1.1 mM; see Table 3 ). This observation strongly suggests that similar to skeletal muscle,37 vascular smooth muscle cannot degrade L-methionine to cysteine via the transsulfuration pathway, probably because of very low activity or absence of the required enzymes. Therefore, the observed changes in plasma cystine concentrations in response to L-methionine infusion are most likely due to enhanced intrahepatic methionine metabolism (see Figure 7) . This concept is further strengthened by the observation that L-cysteine but not L-methionine potentiates the GTN-induced relaxation of canine coronary arterioles in vitro (unpublished observation).
Third, the augmentation of GTN-induced activation of purified soluble guanylyl cyclase activity is signifi-
cantly enhanced by L-cysteine. This suggests that an interaction between the L-methionine conversion product, L-cysteine, and GTN leads to a GTN metabolite formation (nitric oxide or nitrosothiol), which in turn enhances the vasodilator properties of the organic nitrate.
Fourth, the hemodynamic findings with respect to the interaction between L-methionine and GTN are striking similar to reported NAC-GTN interaction.'8 L-Methionine enhanced GTN effects on systemic hemodynamics (Figures 1 and 2) Based on the literature and the present results, we propose the following mechanism for the interaction between L-methionine and GTN (see Figure 7) . L-Methionine is intrahepatically converted to L-cysteine, released into the plasma and oxidized to cystine, taken up by microvessels, and reduced to L-cysteine, thereby replenishing sulfhydryl group stores necessary for improved biotransformation of GTN in very small vessels. 33 This mechanism would explain the ability of L-methionine to potentiate the hypotensive action of GTN in the nontolerant state and the lack of effect on GTN-induced dilation of large coronary arteries in the tolerant and nontolerant states.
It appears implausible that other products in the conversion cascade from L-methionine to L-cysteine (e.g., adenosine, ADP, or a-keto-butyrate) contribute to the observed potentiation of GTN action since the infusion of methionine per se had no vasodilator effects. Furthermore, an extracellular interaction between L-homocysteine and the organic nitrate also appears unlikely since plasma homocystine levels did not change significantly (Table 3) in response to L-methionine infusion. Furthermore, in contrast to L-cysteine, homocysteine failed to augment the nitroglycerin-induced activation of purified guanylyl cyclase in a cell-free buffer system ( Figure 5 ).
Role of Desensitization of Guanylyl Cyclase and Pseudotolerance
It should be stressed that the development of nitrate tolerance is multifactorial.240 Desensitization of vascular smooth muscle to organic nitrates (true tolerance)18 23 and intravascular volume expansion,3 along with activation of neurogenic vasoconstrictor forces (both causing pseudotolerance,12), may contribute to blunting of GTN effects. Several aspects, however, strongly suggest that true tolerance rather than pseudotolerance develops in our model.
At first, the dose-response behavior for epicardial artery dilation in response to the spontaneously nitric oxide-releasing SIN-1, the vasoactive metabolite of sydnonimine molsidomine, is preserved in the nitratetolerant state. 22 This makes it unlikely that mechanisms such as intravascular volume expansion and neurogenic counterregulation mechanisms contribute substantially to the tolerance of epicardial arteries in our model. Second, the administration of ganglionic blockade18 and chronic concomitant administration of ACE inhibitors (unpublished observation) did not reverse completely attenuated responsiveness of epicardial arteries to nitroglycerin in the tolerant state. This nitroglycerinspecific loss of responsiveness of epicardial arteries might involve a decreased liberation of nitric oxide from GTN,41 which in turn might be related to an impairment of the cytochrome P_450. 42, 43 Clinical Implications
The original impulse to use sulfhydryl donors was to reverse nitrate tolerance or to prevent tolerance by their concomitant administration. Although some improvement in hemodynamics in tolerant and nontolerant patients has been reported, the results are disappointing. High intravascular concentrations are apparently required to see this interaction, the degree of potentiation is small in nontolerant patients, and the reversal of tolerance in patients with heart failure is incomplete and short lived. Our results do not support a critical role of diminished intracellular sulfhydryl groups in the development of nitrate tolerance in large epicardial arteries and veins. We conclude that sulfhydryl group supplementation does not represent a therapeutic alternative to a nitrate-free interval as a means of restoring blood vessel sensitivity to nitrates.
